Kiltearn Partners’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$14.2M Sell
30,000
-5,800
-16% -$2.92M 3.82% 11
2025
Q4
$16.7M Sell
35,800
-6,900
-16% -$3.2M 3.62% 10
2025
Q3
$18.2M Buy
42,700
+3,200
+8% +$1.24M 3.65% 9
2025
Q2
$15.1M Sell
39,500
-3,200
-7% -$1.15M 3.04% 11
2025
Q1
$14.8M Sell
42,700
-7,000
-14% -$2.25M 2.81% 13
2024
Q4
$14.9M Sell
49,700
-5,100
-9% -$1.78M 2.46% 16
2024
Q3
$22.3M Sell
54,800
-33,300
-38% -$12.2M 3.03% 13
2024
Q2
$28.3M Sell
88,100
-51,900
-37% -$16.9M 3.43% 12
2024
Q1
$46.2M Sell
140,000
-32,300
-19% -$9.87M 4.27% 9
2023
Q4
$46.6M Buy
172,300
+24,600
+17% +$6.08M 3.59% 13
2023
Q3
$36.3M Sell
147,700
-5,500
-4% -$1.5M 2.87% 14
2023
Q2
$46.5M Sell
153,200
-4,300
-3% -$1.2M 3.4% 14
2023
Q1
$41.5M Buy
157,500
+27,100
+21% +$6.88M 3% 17
2022
Q4
$31.3M Buy
+130,400
New +$29.2M 2.3% 22

Other funds holding HCA